Cat.#: ACPP-1237
| Despition | CRMP1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1344 | Olig2 Blocking Peptide (AC1344) | 250 µg | inquiry |
| ACPP-1419 | Human TAC3 Protein (AC1419) | 5 µg | inquiry |
| ACPP-1701 | Human SERPINA3 Protein (AC1701) | 5 µg | inquiry |
| ACPP-1561 | Mouse EFNB2 Protein (AC1561) | 1 µg | inquiry |
| ACPP-1264 | SorLA Blocking Peptide (AC1264) | 250 µg | inquiry |
| ACPP-1653 | Human CRYM Protein (AC1653) | 2 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1351 | Dopamine D2 Receptor Blocking Peptide (AC1351) | 250 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1689 | Human DUSP26 Protein (AC1689) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.